Pradžia › Bipolinis sutrikimas › Ilinoisas
Bipolinis sutrikimas klinikiniai tyrimai Ilinoisas
7 tyrimai dėl Bipolinis sutrikimas ieško dalyvių vietose Ilinoisas.
Miestai Ilinoisas
Oficialus tyrimo tekstas (anglų kalba)
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- Baber Research Group, Naperville
Renkami dalyviai3 fazė
Amžius nuo 5 iki 17 · Visoms lytims · Atnaujinta 2026-09-25 · NCT06229210Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
- Revive Research Institute, Elgin
Renkami dalyviai3 fazė
Amžius nuo 10 iki 17 · Visoms lytims · Atnaujinta 2026-09-25 · NCT06372964A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Naperville
Renkami dalyviai4 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-18 · NCT07105111A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
- Revival Research Institute, Elgin
- Advanced Quality Medical Research, Orland Park
Renkami dalyviai3 fazė
Amžius nuo 18 iki 74 · Visoms lytims · Atnaujinta 2026-09-02 · NCT07172516A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
- Pillar Clinical Research - Chicago /ID# 272823, Chicago
- Amr Conventions Research /ID# 272867, Warrenville
Renkami dalyviai2 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-08-14 · NCT06696755A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
- Pillar Clinical Research -Chicago, Chicago
Renkami dalyviai3 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-06-23 · NCT07140913Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
- University of Chicago Medical Center, Chicago
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 18 iki 40 · Visoms lytims · Atnaujinta 2026-03-10 · NCT06740383Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.